JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on MacroGenics (MGNX – Research Report) today and set a price target of $24.00. The...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Enanta Pharmaceuticals (ENTA – Research Report) and...
SVB Securities analyst Jonathan Chang reiterated a Buy rating on MacroGenics (MGNX – Research Report) on May 26. The company's shares closed last...
In a report issued on May 4, Stephen Willey from Stifel Nicolaus maintained a Buy rating on MacroGenics (MGNX – Research Report), with a price...
In a report released today, Jonathan Chang from SVB Securities maintained a Buy rating on MacroGenics (MGNX – Research Report), with a price...
BTIG analyst Kaveri Pohlman maintained a Buy rating on MacroGenics (MGNX – Research Report) on February 24 and set a price target of $50.00. The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.